Published Online: Monday, May 1, 2006

Pharmacy Times, in conjunction with Wal-Mart, is pleased to announce the establishment of a national award, to be known as "the RESPy AWARD," to honor outstanding pharmacy students who display exemplary behavior and great potential as community pharmacist candidates. As Ron Chomiuk, vice president of Wal- Mart Pharmacy Operations, stated, "Pharmacy students are the future of our profession, and those selected for this award demonstrate that they are embracing these values through service to their community and will continue to act on these values as pharmacists."

Eight RESPy AWARD winners will be chosen each year, featured in Pharmacy Times magazine, and honored with their respective college of pharmacy. Students selected to receive the award also will receive a cash award and will be offered a summer internship with Wal-Mart.

How to Submit Nominations

Nominations for future RESPy AWARDs can be submitted by deans of pharmacy schools nationwide and should be sent to Emilie McCardell, editorial director of Pharmacy Times, at All nominations will be reviewed by a select panel, including representatives from Pharmacy Times, Wal-Mart, and academia. Some criteria on which the pharmacy student will be selected are as follows:

  • Demonstration of voluntary public service activities
  • Demonstration of a high level of professional/public health- related activities outside the classroom
  • Demonstration of a high level of effort to advance the profession of pharmacy in the public arena

Pharmacy Times would like to congratulate our first RESPy AWARD winner, Candace Thibodeaux. We eagerly await the nomination and selection of future award winners!

The Wal-Mart/Pharmacy Times RESPy AWARD (Respect, Excellence, and Service in Pharmacy) is presented to the student who has made a difference in his/her community by demonstrating excellence in pharmaceutical care.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues